See more : Taiyen Biotech Co., Ltd. (1737.TW) Income Statement Analysis – Financial Results
Complete financial analysis of FTAC Zeus Acquisition Corp. (ZING) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of FTAC Zeus Acquisition Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Intervest Offices & Warehouses (INTO.BR) Income Statement Analysis – Financial Results
- Jasper Therapeutics, Inc. (JSPRW) Income Statement Analysis – Financial Results
- Boomer Holdings Inc. (BOMH) Income Statement Analysis – Financial Results
- The Vitec Group plc (VTC.L) Income Statement Analysis – Financial Results
- IDT Australia Limited (IDT.AX) Income Statement Analysis – Financial Results
FTAC Zeus Acquisition Corp. (ZING)
Industry: Shell Companies
Sector: Financial Services
About FTAC Zeus Acquisition Corp.
FTAC Zeus Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as FTAC Hera Acquisition Corp. and changed its name to FTAC Zeus Acquisition Corp. in February 2021. FTAC Zeus Acquisition Corp. was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Cost of Revenue | 3.32M | 0.00 |
| Gross Profit | -3.32M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 |
| General & Administrative | 0.00 | 807.73K |
| Selling & Marketing | 0.00 | 0.00 |
| SG&A | 0.00 | 807.73K |
| Other Expenses | 3.32M | 0.00 |
| Operating Expenses | 3.32M | 807.73K |
| Cost & Expenses | 3.32M | 807.73K |
| Interest Income | 5.89M | 3.87K |
| Interest Expense | -5.89M | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K |
| EBITDA | -3.32M | -807.73K |
| EBITDA Ratio | 0.00% | 0.00% |
| Operating Income | -3.32M | -807.73K |
| Operating Income Ratio | 0.00% | 0.00% |
| Total Other Income/Expenses | 5.89M | 3.87K |
| Income Before Tax | 2.57M | -803.86K |
| Income Before Tax Ratio | 0.00% | 0.00% |
| Income Tax Expense | 1.19M | -3.87K |
| Net Income | 1.38M | -799.99K |
| Net Income Ratio | 0.00% | 0.00% |
| EPS | 0.03 | -0.05 |
| EPS Diluted | 0.03 | -0.05 |
| Weighted Avg Shares Out | 42.03M | 16.91M |
| Weighted Avg Shares Out (Dil) | 42.03M | 16.91M |
Source: https://incomestatements.info
Category: Stock Reports